Elite Pharmaceuticals Inc
General ticker "ELTP" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $612.5M
Elite Pharmaceuticals Inc follows the US Stock Market performance with the rate: 42.8%.
Estimated limits based on current volatility of 4.3%: low 0.52$, high 0.56$
Factors to consider:
- Current price 142.4% above estimated high
- Earnings for 6 months up through Q2 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-03-31 to 2026-03-31
- 2024-03-31 to 2025-03-31 estimated range: [0.08$, 0.22$]
- 2025-03-31 to 2026-03-31 estimated range: [0.05$, 0.16$]
Short-term ELTP quotes
Long-term ELTP plot with estimates
Financial data
| YTD | 2024-03-31 |
|---|---|
| Operating Revenue | $56.63MM |
| Operating Expenses | $45.84MM |
| Operating Income | $10.79MM |
| Non-Operating Income | $-10.33MM |
| Interest Expense | $0.59MM |
| R&D Expense | $6.88MM |
| Income(Loss) | $0.46MM |
| Taxes | $-19.65MM |
| Profit(Loss) | $20.11MM |
| Stockholders Equity | $57.58MM |
| Inventory | $12.93MM |
| Assets | $83.65MM |
| Operating Cash Flow | $-3.28MM |
| Capital expenditure | $0.81MM |
| Investing Cash Flow | $-0.81MM |
| Financing Cash Flow | $3.39MM |
| Earnings Per Share* | $0.02 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.